Toronto Public Health (TPH) is the public health unit in Toronto, Ontario. It is responsible for delivering public health programs and services, enforcing public health regulations and advising Toronto City Council on health issues. The current unit was formed in 1998, when the former Metropolitan Toronto and its constituent municipalities of Toronto, York, North York, Scarborough, Etobicoke, and East York amalgamated into the current city of Toronto..
Canada's National Advisory Committee on Immunization (NACI) marked its 60th anniversary in 2024, representing six decades of reliable advice supporting Canada's immunization programs. Over the past decade, NACI expanded its mandate to include ethics, equity, feasibility, acceptability, and economic considerations, while adapting its methods to align with international standards and responding to urgent public health needs such as the COVID-19 pandemic. Enhanced collaboration with provinces, territories, Indigenous partners, and global peers has strengthened both the relevance and reach of NACI guidance. With an expanding vaccine landscape, NACI continues to evolve as a trusted national and global resource supporting equitable, evidence-informed immunization policy and practice in Canada.
Background: Beaches are popular summertime destinations in Canada. However, they can be affected by specific fecal pollution sources, increasing the risk of recreational water illness. Objectives: This study was conducted to determine the risks of acute gastrointestinal illness (AGI) among Canadian beachgoers and to evaluate the influence of different fecal indicator bacteria (FIB) and other water quality measures on assessing these risks. Methods: In a prospective cohort design, beachgoers were recruited at sites across Canada from 2023 to 2025. Sociodemographic characteristics and exposures were determined through an on-site survey, with a 7-day follow-up survey to determine risks of AGI. Bayesian mixed-effects logistic regression models were fitted to evaluate the effects of an ordinal water contact variable (no contact, minimal contact, body immersion, and swallowed water) on the incident risk of AGI, with an interaction included for water quality indicators. The levels of six FIB and water quality measures were assessed: Escherichia coli, enterococci DNA, three microbial source tracking DNA markers (human HF183/BacR287, human mitochondria, seagull Gull4), and turbidity. Results: A total of 4085 participants were recruited, with 67.6% completing the follow-up survey. The overall incident risk of AGI was 2.6%. Both swallowing water and body immersion increased AGI risks compared to no water contact: median of 20 excess cases (95% Credible Interval [CrI]: 4, 64) and 5 excess cases (95% CrI: 1, 19) of AGI predicted per 1000 beachgoers, respectively. Escherichia coli and seagull DNA marker levels were associated with AGI among those who had water contact, particularly among those who reported swallowing water. Discussion: While the overall burden of AGI due to beach water contact in Canada was low, increased risks are associated with E. coli levels particularly among those who swallow water. This could be related to fecal contamination from seagulls. However, there is substantial uncertainty in the predicted effect sizes. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Protocols ### Funding Statement This work was supported by the Canadian Institutes of Health Research (CIHR), grant numbers PJT 185894 and PJT 192023 (P.I. Young) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Toronto Metropolitan University Research Ethics Board gave ethical approval for this work (REB# 2023-043). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors [https://github.com/iany33/Beach\_cohort\_AGI][1] [1]: https://github.com/iany33/Beach_cohort_AGI
Importance:Both invasive group A streptococcal (iGAS) infections and the number of persons experiencing homelessness (PEH) are increasing. Protection of PEH from the burden of iGAS infections requires understanding of its epidemiology. Objective:To assess whether the resurgence of iGAS infections after the COVID-19 pandemic included PEH. Design, Setting, and Participants:This cross-sectional study of population-based iGAS surveillance used Canada's National Microbiology Laboratory for emm typing and Statistics Canada and point-in-time counts to identify denominators. Participants included 503 persons with iGAS infections from January 1, 2022, to December 31, 2023, in the Toronto and Peel Region, Canada (population, 4.5 million). Main Outcomes and Measures:The main outcome was disease incidence among PEH over time and compared with housed persons. Secondary outcomes were differences in risk factors, presentation, disease severity, and infecting emm types between PEH and housed persons. Results:Ninety iGAS cases occurred among PEH (median age, 47.0 years [IQR, 37.7-59.5 years]; 66 men [73.3%]) and 413 occurred among housed adults (median age, 58.9 years [IQR, 42.1-73.3 years]; 259 men [62.7%]). iGAS incidence among PEH increased from 270.4 (95% CI, 184.5-383.2) per 100 000 per year in 2022 to 451.2 (95% CI, 348.2-575.7) per 100 000 per year in 2023 (incidence rate ratio [IRR], 1.67; 95% CI, 1.06-2.69), not significantly different than the increase from 3.4 to 7.0 per 100 000 per year among housed persons (IRR, 2.05; 95% CI, 1.67-2.52). iGAS incidence overall was 70.7-fold higher (95% CI, 56.3-fold to 88.7-fold) among PEH than housed persons. Compared with housed adults, PEH were less likely to be immunocompromised (adjusted odds ratio [AOR], 0.29; 95% CI, 0.11-0.73) and were more likely to be persons who inject drugs (AOR, 5.06; 95% CI, 2.79-9.19), to have nonintact skin (AOR, 4.16; 95% CI, 2.45-7.04), and to have iGAS presenting as soft tissue infection (AOR, 1.64; 95% CI, 1.02-2.64). PEH were less likely to die of iGAS than housed adults (AOR, 0.33; 95% CI, 0.12-0.95). Overall, emm1 and emm12 caused 33.7% of iGAS cases (137 of 406) among housed persons, but only 2.2% (2 of 90) among PEH; in contrast, isolates with emm types 49, 74, 80, 82, and 92 caused 77.8% of iGAS cases (70 of 90) among PEH, but only 34.2% (139 of 406) among housed persons (P < .001). The emm types frequently causing iGAS infections among PEH also caused iGAS infections among housed persons and were too highly clonal to assess transmission risk. Conclusions and Relevance:In this cross-sectional study, the post-COVID-19 pandemic resurgence of iGAS infections occurred among both PEH and housed adults, although the incidence among PEH was 70.7-fold greater. Risk factors, clinical presentations, outcomes, and infecting strains were very different. Improved iGAS protection for PEH, such as vaccines, is needed.
To describe the demographic and health profiles of Black people in the African Caribbean Track Study (A/C Study) who consented to linkage to administrative databases, examine variations in healthcare use, and compare these patterns to those observed in the general population to inform efforts to reduce health disparities. Using a matched cohort design, participants who consented to administrative data linkage in the A/C Study were matched 1:10 to general population controls based on age (± 5 years), sex, and census metropolitan area. We compared sociodemographic characteristics, HIV prevalence, and healthcare use using descriptive statistics and logistic regression. Of the 1380 A/C Study participants, 309 provided consent and 115 (8.3
Abstract Background In 2022, Toronto faced one of Canada’s largest mpox outbreaks, disproportionately affecting gay, bisexual & other men who have sex with men (GBMSM). Emerging shortly after COVID‑19, the outbreak required a rapid, trusted, and equity‑centred public health response to reduce transmission and support vaccine uptake amid evolving guidance, limited resources, and resumption of in-person pride celebrations. Description of practice Toronto Public Health (TPH) implemented a community‑informed outbreak communications and immunization strategy. It combined partnership‑based communication with targeted service delivery, developed collaboratively with community‑based organizations trusted by GBMSM communities. Highlights: • Co‑development of culturally relevant & stigma‑free messaging. • Placement of vaccination clinics in settings accessed by GBMSM communities. • Use of text message reminders to encourage completion of two‑dose vaccine series. • Alignment of strategic communications with real‑time epidemiological data & outbreak status. Text message reminders were introduced during periods of renewed transmission risk, particularly when second‑dose completion lagged. Results The communications campaign showed higher recall among GBMSM than the general population, confirming successful targeting. There were 290,051 visits to toronto.ca/mpox for info and vaccine appointment bookings during the campaign period. Of 17,811 text messages sent, there were 2,819 appointment clicks, 714 confirmed bookings, a substantial increase over previous weeks without text message reminders. Lessons learned Community trust and partnership were key. Text message reminders were a low‑cost, high‑impact tool, with the strongest engagement occurring within 24–48 hours of message delivery. This approach is transferable to other jurisdictions managing emerging infections, particularly where trust‑building and vaccine completion are critical to interrupting transmission. Key messages • Community engagement and partnership was essential to co-developing trusted communications for mpox vaccine. • The use of text message reminders increased mpox vaccine uptake, particularly in the 24-48 hours after message.